Clonal Competition: Cisplatin Treatment Drives Dominance of TP53- over Tet2-Mutant Stem Cell ClonesKatharina Wohlan, Margaret A. Goodell, Daniel Hormaechea‐Agulla et al.|Blood|2022Cited by 1